期刊文献+

超临界流体技术合成的复合型骨替代生物材料:体内外生物学评价 被引量:2

Substitution of biomaterials by a composite bone fabricated by supercritical fluid technique:In vivo and in vitro biological evaluation
下载PDF
导出
摘要 背景:在复合材料内部增加细胞黏附性较好的高分子材料或同骨组织羟基磷灰石成分相似的无机材料,可以改善材料的表面化学结构。过去的十几年,产生和发展了许多合成生物降解支架材料的新技术,虽然超临界流体技术应用在合成支架中时间尚短,但有着其他技术不可比拟的众多优点,目前越发受到学者的重视。目的:以聚乳酸和同种异体骨粉为原材料,通过超临界流体技术合成复合型骨替代生物材料,评价其生物学特性。方法:首先将同种异体皮质骨粉与聚乳酸在超临界二氧化碳作用下合成多孔复合型骨生物替代材料。将材料浸提液与成骨细胞系复合培养,体外观察细胞形态、增殖情况;通过材料浸提液皮内注射实验和材料肌袋内埋入实验,体内观察动物的致敏、组织炎症发生情况。结果与结论:体外大体观察该种复合材料形状、大小、孔隙可控,孔径适中,有较好的硬度,体外实验表明细胞相容性良好,对细胞的增殖无毒副作用;体内实验表明材料植入动物体内未发生致敏反应,组织相容性良好,但无异位成骨作用。说明制备的新型复合骨组织生物材料在细胞学和生物相容性检测上可以满足组织工程支架和骨组织替代的要求,该种合成技术及多孔生物材料有广阔发展前景。 BACKGROUND:Polymer based materials can improve surface chemical structure via increasing inside inorganic material.A series of techniques have been produced and developed for synthesizing biodegradable materials,and supercritical fluid technique is a superior one.OBJECTIVE:To substitute biomaterials by a composite bone fabricated by supercritical fluid technique,and to evaluate the biological characteristics of the novel composite biomaterial.METHODS:Granulated allogeneic bone and polymer of lactic acid(PLA) were compounded to fabricate the composite scaffold by the supercritical fluid technique.The composite scaffold was cytological estimated through on osteoblasts line culture.Meanwhile the sensitization and tissue inflammation were observed by animal experiment that the saturation was injected subcutaneously and the scaffold was implanted directly into muscle.RESULTS AND CONCLUSION:The figuration,volume and micro-structure of the scaffold were controllable and the biological characteristics of the novel composite biomaterial were excellent.In vivo test demonstrated that,no sensitization response occurred,but the material had no ability of heterotopic osteogenesis.The results illustrated that the prepared novel composite biomaterial can meet the requirement of cellular compatibility and biocompatibility,which has a broad prospect in future.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2010年第25期4577-4580,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献10

  • 1Elvassore N,Baggio M,Pallado P,et al.Production of different morphologies of biocompatible polymeric materials by supercritical CO2 antisolvent techniques.Biotechnology and Bioengineering.2001;73(6):449-457.
  • 2Harris LD,Kim BS,Mooney DJ.Open pore biodegradable matrices formed with gas foaming.J Biomed Mater Res.1998; 42(3):396-402.
  • 3Barry JJ,Gidda HS,Scotchford CA,et al.Porous methacrylate scaffolds:supercritical fluid fabrication and in vitro chondrocyte responses.Biomaterials.2004;25(17):3559-3568.
  • 4Sachlos E,Czernuszka JT.Making tissue engineering scaffolds work.Review:the application of solid freeform fabrication technology to the production of tissue engineering scaffolds.Eur Cell Mater.2003;5:29-39.
  • 5李冀,张育敏,王志强.骨组织工程支架材料合成技术的进展[J].中华创伤骨科杂志,2006,8(8):773-776. 被引量:16
  • 6Lewandrowski KU,Schollmeier G,Ekkemkamp A,et al.Incorporation of perforated and demineralized cortical bone allografts.Part I:radiographic and histologic evaluation.Biomed Mater Eng.2001;11(3):197-207.
  • 7Scarborough MT.Allograft-allograft healing? Salvage of massive allografts after fracture.Clin Orthop Relat Res.2001;(382):28-33.
  • 8李冀,王志强,张育敏,原林.人工骨传导材料的研究进展[J].中国修复重建外科杂志,2006,20(1):81-84. 被引量:8
  • 9Liu X,Ma PX.Polymeric scaffolds for bone tissue engineering.Ann Biomed Eng.2004;32(3):477-486.
  • 10Bouxsein ML,Turek TJ,Blake CA,et al.Recombinant human bone morphogenetic protein-2 accelerates healing in a rabbit ulnar osteotomy model.J Bone Joint Surg Am.2001;83-A(8):1219-1230.

二级参考文献57

  • 1[1]Truumees E,Herkowitz HN.Alternatives to autologous bone harvest in spine surgery.Univ Pennsylvania Orthopaedic Journal,1999,12:77-88.
  • 2[2]Bohner M.Calcium orthophosphates in medicine:from ceramics to calcium phosphate cements.Injury,2000,31 Suppl 4:37-47.
  • 3[5]Hinz P,Wolf E,Schwesinger G,et al.A new resorbable bone void filler in trauma:early clinical experience and histologic evaluation.Orthopedics,2002,25(5 Suppl):597-600.
  • 4[6]Szpalski M,Gunzburg R.Applications of calcium phosphate-based cancellous bone void fillers in trauma surgery.Orthopedics,2002,25(5 Suppl):601-609.
  • 5[7]Meadows GR.Adjunctive use of ultraporous beta-tricalcium phosphate bone void filler in spinal arthrodesis.Orthopedics,2002,25(5 Suppl):579-584.
  • 6[8]Linovitz RJ,Peppers TA.Use of an advanced formulation of beta-tricalcium phosphate as a bone extender in interbody lumbar fusion.Orthopedics,2002,25(5 Suppl):585-589.
  • 7[9]Gunzburg R,Szpalski M.Use of a novel beta-tricalcium phosphate-based bone void filler as a graft extender in spinal fusion surgeries.Orthopedics,2002,25(5 Suppl):591-595.
  • 8[10]Bohner M.Calcium orthophosphates in medicine:from ceramics to calcium phosphate cements.Injury,2000,31 Suppl 4:37-47.
  • 9[11]Keating JF,McQueen MM.Substitutes for autologous bone graft in orthopaedic trauma.J Bone Joint Surg (Br),2001,83(1):3-8.
  • 10[12]Cassidy C,Jupiter JB,Cohen M,et al.Norian SRS cement compared with conventional fixation in distal radial fractures.A randomized study.J Bone Joint Surg (Am),2003,85(11):2127-2137.

共引文献20

同被引文献22

  • 1Einhom TA.Enhancement of fracture-healing[J].J Bone Joint SurgAm,1995,6:940-956.
  • 2Westerhuis RJ,van Bezooijen RL,Kloen P.Use of bone morphogenet-ic proteins in traumatology[J].Injury,2005,12:1405-1412.
  • 3Bauer TW.Bone graft substitutes[J].Skeletal Radiol,2007,12:1105-1107.
  • 4Cricchio G,Lundgren S.Donor site morbidity in two different approa-ches to anterior iliac crest bone harvesting[J].Clin Implant Dent,2003,3:161-169.
  • 5Clavero J,Lundgren S.Ramus or chin grafts for maxillary sinus inlayand local onlay augmentation:comparison of donor site morbidity andcomplications[J].Clin Implant Dent,2003,3:154-160.
  • 6国家技术监督局.GB/T16886.12-2005医疗器械生物学评价第12部分:样品制备与参照样品[S].北京:中国标准出版社,2005.
  • 7Mathieu LM,Montjovent MO,Bourban PE,et al.Bioresorbable com-posites prepared by supercritical fluid foaming[J].J Biomed MaterRes A,2005,1:89-97.
  • 8Bruinink A,Luginbuehl R.Evaluation of biocompatibility using invitro methods:interpretation and limitations[J].Adv Biochem EngBiotechnol,2012,126:117-152.
  • 9Williams DF.On the mechanisms of biocompatibility[J].Biomateri-als,2008,20:2941-2953.
  • 10Wang P,Henning SM,Heber D.Limitations of MTT and MTS-basedassays for measurement of antiproliferative activity of green tea poly-phenols[J].PLoS One,2010,4:10202.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部